Mapua, Salum A. http://orcid.org/0000-0002-3309-4328
Finda, Marceline F.
Nambunga, Ismail H.
Msugupakulya, Betwel J.
Ukio, Kusirye
Chaki, Prosper P.
Tripet, Frederic
Kelly, Ann H.
Christofides, Nicola
Lezaun, Javier
Okumu, Fredros O.
Funding for this research was provided by:
Wellcome Trust (212633/Z/18/Z)
Consortium for Advance Research Training (087547/Z/08/Z)
Bill and Melinda Gates Foundation (OPP1177156)
Howard Hughes Medical Institute (OPP1099295)
Application of Novel Transgenic Technology and Inherited Symbionts to Vector Control (AVPP0027/1)
Article History
Received: 14 October 2020
Accepted: 20 February 2021
First Online: 2 March 2021
Change Date: 9 June 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12936-021-03778-z
Ethics approval and consent to participate
: Ethical approvals for this project were obtained from Ifakara Health Institute’s Institutional Review Board (Protocol ID: IHI/IRB/EXT/No: 007-2018) and the Medical Research Coordinating Committee (MRCC) at the National Institute for Medical Research, in Tanzania (Protocol ID: NIMR/HQ/R.8a/Vol.IX/2895), as well as University of the Witwatersrand (UW) in South Africa (Clearance certificate No. M180820). Written consents were sought from all participants of this study, after they had understood the purpose and procedure of the discussions.
: Permission to publish this study was obtained from National Institute for Medical Research, in Tanzania (NIMR/HQ/P.12 VOL XXXI/67).
: The authors declare no competing interests.